IXR
Ann.out
Robust Scoping Study Outputs Base Case lays foundation,
Extension of Life Potential Remains
Post tax long term free cash flow US$766 million over 11 years
• EBITDA of US$1.28 billion
• Post tax Net Present Value (8) of US$321 million
MC currently $88m
